[HTML][HTML] Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection

PP Sfikakis, KM Verrou… - Frontiers in …, 2021 - frontiersin.org
The reasons behind the clinical variability of SARS-CoV-2 infection, ranging from
asymptomatic infection to lethal disease, are still unclear. We performed genome-wide …

Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection

PP Sfikakis, KM Verrou… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
The reasons behind the clinical variability of SARS-CoV-2 infection, ranging from
asymptomatic infection to lethal disease, are still unclear. We performed genome-wide …

Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection.

PP Sfikakis, KM Verrou… - Frontiers in …, 2021 - europepmc.org
The reasons behind the clinical variability of SARS-CoV-2 infection, ranging from
asymptomatic infection to lethal disease, are still unclear. We performed genome-wide …

[HTML][HTML] Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection

PP Sfikakis, KM Verrou… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
The reasons behind the clinical variability of SARS-CoV-2 infection, ranging from
asymptomatic infection to lethal disease, are still unclear. We performed genome-wide …

Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection.

PP Sfikakis, KM Verrou… - Frontiers in …, 2021 - europepmc.org
The reasons behind the clinical variability of SARS-CoV-2 infection, ranging from
asymptomatic infection to lethal disease, are still unclear. We performed genome-wide …